• Beyond B Cells: Translating Ibrutinib Mechanisms

  2026-08-19

  Ibrutinib (PCI-32765) offers a powerful framework for interrogating BTK-dependent biology, from B-cell receptor signaling inhibition and chronic lymphocytic leukemia research to biomarker-led studies inspired by ATRX-deficient glioma research. This article separates established evidence from forward-looking hypotheses and provides a practical strategy for translational validation.

• Tropifexor (LJN452) Workflow for FXR Studies

  2026-08-19

  Tropifexor (LJN452) enables low-nanomolar interrogation of FXR signaling in intestinal barrier, liver, and metabolic disease models. This practical workflow combines dose-response design with compartment-aware metabolic readouts inspired by recent triacetin research.

• BMS 309403 and the FABP4 Atherosclerosis Axis

  2026-08-18

  A translational framework for using BMS 309403 to connect FABP4-driven lipid handling, inflammation, foam-cell biology, and cardiometabolic disease models.

• MHY1485: Practical mTOR Activator Workflows

  2026-08-18

  MHY1485 provides a controllable way to activate mTOR while interrogating autophagy, lipid metabolism, and ovarian follicle models. This guide connects product handling with assay design, quantitative controls, and troubleshooting strategies for reproducible cell and ex vivo experiments.

• LINC01278, mTOR Signaling, and Uveal Melanoma

  2026-08-17

  The reference study identifies LINC01278 as an autophagy-related long noncoding RNA that suppresses uveal melanoma progression through inhibition of the mTOR signaling pathway. By combining bioinformatics, pharmacological pathway perturbation, cellular assays, and a xenograft model, the work connects a prognostic RNA candidate with a testable tumor-suppressive mechanism.

• Chlorpromazine HCl in Neuroimmune Research

  2026-08-17

  Chlorpromazine HCl gives researchers a versatile way to study dopamine receptor inhibition, neuronal signaling, and host-directed macrophage responses in parallel. This guide translates product specifications and recent phenothiazine findings into practical workflows, controls, and troubleshooting strategies.

• Purmorphamine Workflows for Smoothened Research

  2026-08-16

  Purmorphamine is a direct Smoothened agonist for testing Hedgehog pathway control in osteogenic, stem-cell, neural, and sensory assays. This guide translates product specifications and honeybee Smo findings into practical dosing, readout, and troubleshooting strategies.

• AG-221 (Enasidenib) in IDH2 AML Research

  2026-08-15

  AG-221 (Enasidenib) enables a layered workflow linking IDH2 inhibition to 2-hydroxyglutarate reduction, leukemia cell differentiation, and metabolic dependency. This practical guide shows how to combine pharmacodynamic, phenotypic, and CD44-focused assays to investigate resistance in acute myeloid leukemia research.

• Cy5 TSA Fluorescence System Kit: Lab Guide

  2026-08-14

  A practical, scenario-driven guide to using the Cy5 Tyramide Signal Amplification (TSA) Fluorescence System Kit, SKU K1052, for sensitive endpoint detection in immunocytochemistry, immunohistochemistry, and in situ hybridization. It covers assay compatibility, protocol controls, quantitative interpretation, and evidence-based product selection for cell biology workflows.

• 3-Deazaadenosine hydrochloride in HSC Assays

  2026-08-14

  Use 3-Deazaadenosine hydrochloride as a chemical probe for SAHH-dependent methyl metabolism while dissecting the IGF2BP1–TUBB4B–FAK pathway in hepatic stellate cells. The workflow combines dose-response profiling, methylation-aware RNA analysis, and fibrosis-relevant phenotyping rather than treating SAHH inhibition as a substitute for direct genetic validation.

• SCH772984 HCl: ERK1/2 Inhibitor Workflows

  2026-08-13

  SCH772984 HCl enables direct, nanomolar ERK1/2 pathway inhibition for studying MAPK reactivation, tumor-cell growth, and transcriptional control of TERT. This practical guide connects phospho-ERK assays with proliferation, chromatin, and stem-cell workflows while emphasizing dose design and troubleshooting.

• Crystal Violet Staining Solution for Biomass Logic

  2026-08-13

  Crystal Violet Staining Solution is more than a nuclear staining dye: it is a practical endpoint for measuring attached cellular or biofilm biomass. This guide connects assay chemistry, LL-37 biofilm evidence, workflow controls, and interpretation limits to improve reproducibility.

• Salvianolic acid B: Readouts That Matter

  2026-08-12

  Salvianolic acid B research is strongest when LH2 expression, collagen modification, and matrix remodeling are measured as connected but distinct outcomes. This article presents an evidence-centered assay strategy for evaluating Dan Shen Suan B in pulmonary fibrosis models without overstating mechanism or translational readiness.

• ACE2–Sirt1 Mitochondrial Biogenesis in Sepsis

  2026-08-12

  The February 2024 reference study identifies ACE2 downregulation as a feature of sepsis-induced cardiomyopathy and connects ACE2 activation with MasR–Sirt1-dependent mitochondrial biogenesis. Its complementary activator–inhibitor design links this pathway to cardiac dysfunction, inflammation, oxidative stress, and cardiomyocyte apoptosis in a mouse sepsis model.

• DAF-2 Diacetate for Nodule NO Assays

  2026-08-11

  DAF-2 diacetate provides a practical fluorescence strategy for connecting nitric oxide chemistry with sulfur-dependent soybean nodule senescence. This guide translates recent symbiosome research into assay design, controls, imaging decisions, and interpretation limits.

16764 records 1/1118 page Next 12345 下5页 Last page